These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 17312390)
1. IGFBP7 plays a potential tumor suppressor role in colorectal carcinogenesis. Ruan W; Xu E; Xu F; Ma Y; Deng H; Huang Q; Lv B; Hu H; Lin J; Cui J; Di M; Dong J; Lai M Cancer Biol Ther; 2007 Mar; 6(3):354-9. PubMed ID: 17312390 [TBL] [Abstract][Full Text] [Related]
2. IGFBP7 plays a potential tumor suppressor role against colorectal carcinogenesis with its expression associated with DNA hypomethylation of exon 1. Ruan WJ; Lin J; Xu EP; Xu FY; Ma Y; Deng H; Huang Q; Lv BJ; Hu H; Cui J; Di MJ; Dong JK; Lai MD J Zhejiang Univ Sci B; 2006 Nov; 7(11):929-32. PubMed ID: 17048309 [TBL] [Abstract][Full Text] [Related]
3. IGFBP7 is a p53-responsive gene specifically silenced in colorectal cancer with CpG island methylator phenotype. Suzuki H; Igarashi S; Nojima M; Maruyama R; Yamamoto E; Kai M; Akashi H; Watanabe Y; Yamamoto H; Sasaki Y; Itoh F; Imai K; Sugai T; Shen L; Issa JP; Shinomura Y; Tokino T; Toyota M Carcinogenesis; 2010 Mar; 31(3):342-9. PubMed ID: 19638426 [TBL] [Abstract][Full Text] [Related]
4. Decreased expression of SCUBE2 is associated with progression and prognosis in colorectal cancer. Song Q; Li C; Feng X; Yu A; Tang H; Peng Z; Wang X Oncol Rep; 2015 Apr; 33(4):1956-64. PubMed ID: 25672935 [TBL] [Abstract][Full Text] [Related]
5. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748 [TBL] [Abstract][Full Text] [Related]
6. The insulin-like growth factor binding proteins 3 and 7 are associated with colorectal cancer and liver metastasis. Georges RB; Adwan H; Hamdi H; Hielscher T; Linnemann U; Berger MR Cancer Biol Ther; 2011 Jul; 12(1):69-79. PubMed ID: 21525788 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic Downregulation and Growth Inhibition of IGFBP7 in Gastric Cancer. Kim J; Kim WH; Byeon SJ; Lee BL; Kim MA Asian Pac J Cancer Prev; 2018 Mar; 19(3):667-675. PubMed ID: 29580038 [TBL] [Abstract][Full Text] [Related]
8. IGFBP7 is a p53 target gene inactivated in human lung cancer by DNA hypermethylation. Chen Y; Cui T; Knösel T; Yang L; Zöller K; Petersen I Lung Cancer; 2011 Jul; 73(1):38-44. PubMed ID: 21095038 [TBL] [Abstract][Full Text] [Related]
9. IGFBP7 is associated to prognosis and could suppress cell survival in cholangiocarcinoma. Yue C; Yang M; Tian Q; Mo F; Peng J; Ma Y; Huang Y; Wang D; Wang Y; Hu Z Artif Cells Nanomed Biotechnol; 2018; 46(sup2):817-825. PubMed ID: 29991293 [TBL] [Abstract][Full Text] [Related]
10. IGFBP7 is associated with poor prognosis in oesophageal adenocarcinoma and is regulated by promoter DNA methylation. Smith E; Ruszkiewicz AR; Jamieson GG; Drew PA Br J Cancer; 2014 Feb; 110(3):775-82. PubMed ID: 24357797 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-binding protein-7 (IGFBP7) transcript: A-to-I editing events in normal and cancerous human keratinocytes. Hochberg M; Gilead L; Markel G; Nemlich Y; Feiler Y; Enk CD; Denichenko P; Karni R; Ingber A Arch Dermatol Res; 2013 Aug; 305(6):519-28. PubMed ID: 23543219 [TBL] [Abstract][Full Text] [Related]
12. HSP60, a protein downregulated by IGFBP7 in colorectal carcinoma. Ruan W; Wang Y; Ma Y; Xing X; Lin J; Cui J; Lai M J Exp Clin Cancer Res; 2010 Apr; 29(1):41. PubMed ID: 20433702 [TBL] [Abstract][Full Text] [Related]
13. IGFBP7 downregulation is associated with tumor progression and clinical outcome in hepatocellular carcinoma. Tomimaru Y; Eguchi H; Wada H; Kobayashi S; Marubashi S; Tanemura M; Umeshita K; Kim T; Wakasa K; Doki Y; Mori M; Nagano H Int J Cancer; 2012 Jan; 130(2):319-27. PubMed ID: 21328580 [TBL] [Abstract][Full Text] [Related]
14. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656 [TBL] [Abstract][Full Text] [Related]
15. Low expression of IGFBP7 is associated with poor outcome of pancreatic ductal adenocarcinoma. An W; Ben QW; Chen HT; Zheng JM; Huang L; Li GX; Li ZS Ann Surg Oncol; 2012 Nov; 19(12):3971-8. PubMed ID: 22622471 [TBL] [Abstract][Full Text] [Related]
16. Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma. Bolomsky A; Hose D; Schreder M; Seckinger A; Lipp S; Klein B; Heintel D; Ludwig H; Zojer N J Hematol Oncol; 2015 Feb; 8():10. PubMed ID: 25887188 [TBL] [Abstract][Full Text] [Related]
17. ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma. Chen YB; Liao XY; Zhang JB; Wang F; Qin HD; Zhang L; Shugart YY; Zeng YX; Jia WH Int J Oncol; 2017 Feb; 50(2):622-630. PubMed ID: 28035363 [TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Ma Y; Lu B; Ruan W; Wang H; Lin J; Hu H; Deng H; Huang Q; Lai M Exp Mol Pathol; 2008 Oct; 85(2):141-5. PubMed ID: 18701096 [TBL] [Abstract][Full Text] [Related]
19. Oncofetal H19-derived miR-675 regulates tumor suppressor RB in human colorectal cancer. Tsang WP; Ng EK; Ng SS; Jin H; Yu J; Sung JJ; Kwok TT Carcinogenesis; 2010 Mar; 31(3):350-8. PubMed ID: 19926638 [TBL] [Abstract][Full Text] [Related]
20. IGFBP7: an oncosuppressor gene in thyroid carcinogenesis. Vizioli MG; Sensi M; Miranda C; Cleris L; Formelli F; Anania MC; Pierotti MA; Greco A Oncogene; 2010 Jul; 29(26):3835-44. PubMed ID: 20440262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]